Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
This section outlines the evolution and milestones of Behemothlabz from its founding in 2014 to its continued growth and innovation in 2024.
This section provides all our contact details, encouraging you to reach out for assistance or inquiries. It encompasses live chat, phone support, and email options, ensuring accessibility for all.
Discover all you need to know to partner with us and promote our products to earn rewards.
In our FAQs section, we have compiled answers to the questions we frequently receive. Quickly find information about our company, products, and policies. If you have any questions, you might find the answer here before reaching out to us directly.
In our Quality Control and Testing section, we uphold Behemothlabz’s Commitment to Quality by meticulously detailing our procedures.
Sign up Here for our regular newsletter and stay updated.
Gonadorelin is a gonadotropin-releasing hormone (GnRH) agonist. GnRH causes the pituitary gland to potentially increase the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In men, LH and FSH increase testosterone production. In women, they have the potential to boost estrogen production. [R]
Packaged in an air-sealed mylar bag. Keep contents sealed and stored in a cool dry place. Items are shipped in a plain envelope or bubble mailer within 24-48 hours (or the next business day).
Gonadorelin, also referred to as Gonadotropin-Releasing Hormone (GnRH), is a synthetic peptide with significant implications in the field of endocrinology and reproductive research. It is derived from a decapeptide sequence within the native GnRH and plays a pivotal role in regulating the release of gonadotropins, namely luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland.
Gonadorelin operates by binding to and activating the GnRH receptors on the anterior pituitary gland. Upon binding, it triggers the synthesis and secretion of LH and FSH, which, in turn, stimulate the production of sex hormones, such as testosterone in males and estrogen and progesterone in females. This hormonal cascade is integral to the regulation of reproductive processes and gonadal function.
Gonadorelin’s research applications are diverse and span several crucial areas of study. Its primary function as a regulator of gonadotropin release makes it an indispensable tool in reproductive and endocrinological research. Here are some key research benefits:
Recent data suggesting the potential use of GnRH analogs with fewer side effects for breast cancer prevention in postmenopausal women has led to the proposal of utilizing gonadorelin for breast cancer prevention within this specific demographic. A separate study demonstrated how the administration of GnRH analogs can effectively reduce circulating concentrations of estrogen in postmenopausal women by blocking estrogen receptors, a group at the highest risk of developing breast cancer. Several studies have linked the anti-tumoral properties of gonadorelin to the reduction in the proliferation, invasion, and migration of breast cancer cells. Furthermore, gonadorelin has exhibited the ability to increase apoptosis and inhibit the metastasis of breast cancer cells [R] [R] [R].
In a 2016 study, a male subject diagnosed with hypogonadotropic hypogonadism (HH), azoospermia (lack of sperm in ejaculate), and a history of prior anabolic steroid use underwent gonadotrophin therapy, ultimately achieving conception [R].
Additionally, GnRH has shown promise in inducing spermatogenesis, resulting in the production of mature sperm in approximately 85% of patients. On average, about 60% of couples achieved pregnancy after just nine months of treatment [R] [R].
Research indicates that a treatment called combined androgen blockade (CAB), which combines gonadorelin with other localized compounds commonly used to treat prostate cancer, can effectively cure at least 90% of localized prostate cancer cases. Early diagnosis of prostate cancer is highly achievable with currently available diagnostic techniques, making death from prostate cancer an exception [R].
In a clinical trial involving 22 young male patients with hypogonadotropic hypogonadism (HH) and 20 healthy controls, the impact of gonadorelin treatment on bone mineral density was assessed. Following six months of pulsatile gonadorelin treatment, there was a significant increase in bone mineral density in areas including the lumbar spine 2-4, femoral neck, and total hip. The increase was statistically significant in all of these regions [R].
A 2005 study revealed that both LH and GnRH possess neuronal receptors, with LH known to cross the blood-brain barrier. The study further identified that receptors for LH are most concentrated in the hippocampus, a brain region susceptible to Alzheimer’s disease (AD). [R]
Gonadorelin is instrumental in studying the intricate interactions of the hypothalamic-pituitary-gonadal (HPG) axis, which plays a central role in regulating reproductive processes and the release of sex hormones. Researchers use Gonadorelin to gain insights into the control of these processes.
Gonadorelin can indeed be employed for this purpose. It helps researchers investigate the underlying hormonal irregularities in conditions like hypogonadism and other sex hormone-related disorders. Its ability to stimulate the release of LH and FSH makes it a valuable tool in understanding and potentially addressing these imbalances.
Gonadorelin, a synthetic peptide with a pivotal role in the regulation of gonadotropins, is an invaluable asset in endocrinology and reproductive research. Its capacity to stimulate the release of luteinizing hormone and follicle-stimulating hormone makes it a key player in studies related to the hypothalamic-pituitary-gonadal axis, fertility treatments, reproductive disorders, and the diagnosis of hormone-secreting tumors. With its multifaceted applications, Gonadorelin continues to be a cornerstone of research in these vital scientific domains.
Behemoth Labz has established itself as a reliable and reputable source for research compounds since 2014. We take pride in offering the highest-quality products that are backed by independent, third-party-issued Certificates of Analysis for identification, purity, and concentration.
Our commitment to quality extends to every aspect of our business, from same-day processing to free shipping on all orders over $100 and our satisfaction guarantee.
At Behemoth Labz, we understand the importance of having access to the best compounds for research purposes. Our team is dedicated to providing exceptional customer service and ensuring that our customers have access to the compounds they need to conduct groundbreaking research.
We also offer international shipping to our customers around the world. Our team is committed to ensuring that your order arrives after research is needed to fully understand its mechanisms of action and potential applications in the treatment of various conditions.
Please make sure you go through the Terms and Conditions, and please familiarize yourself with it as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product.
Customer satisfaction is our number one priority!
ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or and veterinary purposes.
Strength | 100mcg per spray/10mg/10ml |
---|
Reviews
There are no reviews yet